# NHS England (Additional Functions) Regulations 2017, Regulation 4: Power to conclude and manage framework agreements

Extent: E+W

(1) NHS England may conclude and manage framework agreements to facilitate the purchase and supply of a service, drug, medicine or other substance or product to which paragraph (2) applies.
(2) This paragraph applies to a service, drug, medicine or other substance or product that is to be provided as part of the health service for—
(a) the purposes of preventing, diagnosing, monitoring or treating a physical or mental illness;
(b) the purposes of providing care to an individual; or
(c) a purpose related to any matter mentioned in sub-paragraph (a) or (b).
(3) In this regulation—
(a) “framework agreement” means an agreement between NHS England and one (or more than one) supplier, the purpose of which is to establish the terms governing contracts to be entered into during a given period, in particular with regard to price and, where appropriate, the quantity envisaged; and
(b) “other substance or product” includes—
(i) medical supplies within the meaning of section 260(5) of the 2006 Act;
(ii) a medical device within the meaning of regulation 2 (interpretation) of the Medical Devices Regulations 2002; and
(iii) a human blood component.

---
Source: https://www.legislation.gov.uk/uksi/2017/212/regulation/4 (the official version)
Page: https://openlegislation.uk/nhs-england-additional-functions-regulations-2017/regulation-4
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.